pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-497 |
Genomic Coordinates | chr17: 7017911 - 7018022 |
Synonyms | MIRN497, hsa-mir-497, MIR497 |
Description | Homo sapiens miR-497 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-497-3p | ||||||||||||||||||||||||||||
Sequence | 64| CAAACCACACUGUGGUGUUAGA |85 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SNX2 | ||||||||||||||||||||
Synonyms | TRG-9 | ||||||||||||||||||||
Description | sorting nexin 2 | ||||||||||||||||||||
Transcript | NM_003100 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SNX2 | |||||||||||||||||||||
3'UTR of SNX2 (miRNA target sites are highlighted) |
>SNX2|NM_003100|3'UTR 1 CAATAAGATTGTTGCCGTTAAGAAGACCTTGGATGTTGTTCCAGTTATGCTGGATTCCACAGTGAAATCATTTAAAACCA 81 TCTAAATAAACCACTATATATTTTATGAATTACATGTGGTTTTATATACACACACACACACACACACACACACACACACA 161 CACTCTGACATTTTATTACAAGCTGCATGTCCTGACCCTCTTTGAATTAAGTGGACTGTGGCATGACATTCTGCAATACT 241 TTGCTGAATTGAACACTATTGTGTCTTAAATACTTGCACTAAATAGTGCACTGCAAGACCAGAAAATTTTACAATATTTT 321 TTCTTTACAATATGTTCTGTAGTATGTTTACCCTCTTTATGAAGTGAATTACCAATGCTTTGAATAATGTTCACTTATAC 401 ATTCCTGTACAGAAATTACGATTTTGTGATTACAGTAATAAAATGATATTCCTTGTGAAATATTAGTAACAAATTATTTG 481 GGTATTTAAACATTAGGAATCTTTTCAAAGCATTTTTAATAGGAAGAAATTTTTCTTCTAGATGTATATAGGTGATGCCA 561 TGATTCCTTAATTATTTTAATTGACAAAGCTGAACTCATTAAATGACTAAATGAAGCTTAAGTTTTCTTATGAAACCATC 641 ATAAATCAAAGAACATTTGACTCTTGATTGTCTTGGGTAAAGAAGAGAATAATTGTCTTTGCTTGTTTTTAACCATCTCT 721 ATTACAAGTGCCCAATTTAAGAATTAGGAAAAAAATGTATTTATATACTTTTACAAGTCCCATGGATTTTGTTCATCTTC 801 TCGTTATCTTCAGAATCTCGTACTTTGCATATATTTAATTTATTCTTGTCTTTTGGTTTTTTTTCTTTTAAACTAAAAGT 881 ATATCATCTGTGCTCACAGTTGACAAGGAATGGTACCATGTTAAAATATACCATGATTTGATGAATAAGCAAGCACAACA 961 CAAAGCAAATTTGAAGTAAACTGAAATTTAGTTTGCCTTGGGCAATGTTTTTACCCATTCTGTATGCTACTTAGACAGCT 1041 GTTATCTAATCCTTAATGCTGATGAAAATTTAAGTCATGGCTGGGTGTGGTGGCTCACGCCTGTAATCCTAGCACTTTGG 1121 GAGGCTGAGGTGGGTGGATCACCTGAGGTCAGGAGTTCAAGACTAGCCTGGCCAACATGGTAAAACTCCATCTCTACTAA 1201 AAATACAAAAATTCGCCTGGTGTGGTGGGGTGTGCTTGTGGTCCCAGCTACTTGGGAGGCTGAGGCACAAGAATCGCTTG 1281 AACCAGGAAGGTGGAGGTTGCAGTGAGCCAAGATCATGCCGTTGCACGCCAGCCTAGGCAACAAAAGCAAAACTCCATCT 1361 CAAAAAAAAAAAAAAAAAAAAAAAAGATGACTGGTGTCAGAGCTATTTTTGTTTTTTAAAAAATATTCTTACAAACACCC 1441 CTCTTCTTGAGCTTAACCACCACATATCCCTTCCATAGGAACAAGATATGGTATGTGTAACTAAGTCATCTCTAGTGAGT 1521 CACTGGATACAATTTATATATCGAAGTATCCTTAGCATGTGTTTGCTTCTGCTTTAGTTGAAATGTTAAGCCTTCTATAG 1601 GTGTTATTCATATTTATACTCCCACAGCCCAGAAGAGTGGCTGATACATAATAGGTTAATAATAAGGGCTTGATGGGCCA 1681 GGCACAGTGACTCACATGCCTGTAGTCCCAGCTTCTTGGGAGGCTGAGGCAGGAGGATCTCTTGAGCCCAGGAGTTTGAG 1761 GCTATAGTACACTATGATCGTGCCTGTGAATACCCACTAACCTACAGCCAGCCTGGACAACATAGTGAGACCCTGTCTCT 1841 AAAAAAAATGAAGACTTGATGAGTTGAACAGGGAAAACAAAAGTTTGCTCTTCTAAAAAGAAACTGAAGCAGAAATAGTA 1921 CAATCATCTTTTGTTGCTTCTGGGAATACTTTTCAGAAACGAATAATTCATAGTAATATATATCAGATGCTATCTTGTTG 2001 CTCCATTAATATTGAGCAAAAGATAGGCTTACCAAGAATAGTTTCACTATAATGATGTCCTAGTGTTATATCCACAGGTA 2081 TATTACTTAACAAAGGTATAGTTTACACATAGGATGGTTATTCAAGTTATTATTAAAATCTTCCATTCAGATGTGGTACA 2161 TTAGAATATTCAGTACCTCCAAGTAAAATAATAAATATTTTCAGCCTTGATTAAACTCTAGACTCCCTTCCAGACTTCCA 2241 TTTCCCTTGCCCACATTTACTAAAAGATGAGTGTGCTGGAAATTTCAAGTATTATATGAGCCTCTGATACCTACCAGTAT 2321 TTAAACAGGATTTAATTATTTCAACACTTCACCCATCAATCTTCACTTCTCCTGTTCAGATAAAAATGCTTTCATCCCAA 2401 ATAAGTAAAACAAGAACATTAATAGTGCTAATAATATAATCTTTTCATTGGATAGGTCTGAGTTTAGCGTTTGTTTGTTT 2481 TCTTAATGAGATCAAAAGTTAAAGACCAAGGCAGCAAAATATTGTGAAACAAGCTGAACTTGGGATCAGCATACATTTGT 2561 TCAGTCTTGTTTCATTTAGTATGACTTTGGGCATATCACTTAAATCTCTTATCTATAAAACAAGTACATAAAAGTCTTGA 2641 TTCCTGAAGTGCCTTTCTACTTTAAAATATTTTGTTTAAAATATCAAACTTCAATATAAATATGTTGGAAAACAATTCTA 2721 ATCAAAGAACTTCTATTAAGTAAAACAAGACAAAATGTGTGTAAAAATATGCCTAACACATAGATTTCCTTGATTGTATT 2801 TTCTACTGAACTATTTTCAAGTATTCAGCTTTATACTAATATATTAATCTCAAAATACCTTTGTTTCATTGTTGCTACTC 2881 CTTAAACTTTTTTCTTTATTATCTAGATCTAGTAAAGTTTTCTGCATTCATTGTATTAATGTTGGTTCAAAAGTAATTGC 2961 GTCCTTTGTCGTTATATAAATTGTTTTATAAATGGCTTTAACTATGACATAAGCCTTTTAACATAATCAGCTTTCTTTAA 3041 AGGAGGAAGTCAGATGAGTAGAGAAGGAAAGTTATATTCCTTTACAAATGCTCTTAATTTTAATGTCTTAAGGGAATTAT 3121 AGAGACTTCCATTATTCTGCCTTAAATAAGGGATGTTACTTCAGTTTTCTTGTCATGGCTCCCTGCATGGGCAGTCATGT 3201 TAACAAGAGTCAGGGAGATAGCAGATATTCCATAATAGTGACTGCAGATAGGCCAGTCAAAGTCATTTTGTTTTAAAGGA 3281 AGGGAGGTTGCTGGTAGTTAGGTGGGAAAATAACACCTGTGAAAAGGAAGTCCAAGTCACTGGCTCAGGGACTTTGGAGG 3361 CATTTTCATATCATATTCACTAGTCAAGAAACGTGTAGATTATATGTGTGAGTGACATAGTCTGTTTCAAAGTATTAGAA 3441 AAGAGACAATAGAATCACCCACCCTCCCTTCGACACACACTTCCTTATGTAAAATCAGAATCAAATAATTATCATTCCTA 3521 ACCCTCACAGTGAAGGATTTGGTTTCATGTAACAATGAAAGTAGATAATGGGTCAGACATGGAAATAGCAATAAAAGGGA 3601 ATTACAACAAGATAAATGTGAGTAATAGTTCATTTTCCTGCATTTTTGATGAGGGCCATGAAGATAGGTCATGGTAATCT 3681 ATGGAGAAGGTCCTTAAGAGCATAGAACAATATAAATATAATATGGGCCATATATATAATTTTAAAATTTTCTACAGCCA 3761 AATGTTAAAAAGTAAAAAACAATTTTAATAATCCAGTAGCTCCAAAATATTATTTTAATATGTAATCCAATATATTGAAG 3841 TTATAAGATATTTTACATTCTTTTTTTGATATCTGATGTATATTTTACACTTTCATCACATCTCCATTCAGACCGGCTAC 3921 AATTTGATCAGTTGTCACATGTGGATGACTAGTGGCTATGATAATGGACAGCATAGGTTTAGACAATGCCTATTCAACTA 4001 TTCAACTTGTTTTACATTTATAAATCTCAAAATGCCTTTATTTCATTGTTGGTACTCTTTTTTATTACCCAGATACAATA 4081 AAGTTTTCCAAGTTTCATTGTACACATGAAATGAGTTTACTGTGGAAATGAAAATGCAGAGTAAGTCCAACAGCTAGTTT 4161 ATCATCCTGAACCCAGTGAAGAAATCAAAGCTGAATAAAAGCGACTCCTAGTTGTTACTCTCAAGGGCAGGTATAATTTA 4241 TGTGCAAGACTTTGTAGCATAATGTTTTGCAAGTAGTGGATGTTCAATATCTACAATAAATGAATTGTAGTACTATATTG 4321 CTTGAAGGAAGTTTATAACCTGTCTAGAACAACTTTCTCAATTTTACAACTAAACTAGGAGATCCAGGGCTTAAATCATG 4401 ATTGAACTGATTATTCCTGTTAAATTTATGTGTGAACCATATGTGAACATTCTTTGAAAATGTATGATAAGCATTTCAAG 4481 ATTTCTGTTTTAATTATTAACATTTAGAATTCTAGGAAATCTTTTGGGATACAGAGAACTTATTTCTTCCAACTGTTGCT 4561 TCAGACGCTGATAAGATTGTAGAAGATAGGGAAGCTGTAGTTTACTATCTAGTTTTTTAATGCACATGAAGTAATTTAAA 4641 ATGCTCTTCTTCCTTTCTTGTCACATACTTTTAAAAAATTCTCTAAAGATTGAATAATTTTAAGTATTTCTTAACTGGGC 4721 AAAATGGAAACTTTGTAACTGAAGCCAGTCAAGGTGAATACACAGAAAATCATTTTCTTATTAAGGTCAGTTAATGGGAT 4801 AAACCGTTTTAAGAGAGTTGAGAAAAAATAAAGTTCTATTTTAAATTTATACATGTAACTTTAATAAAAACTAAGTCAGA 4881 CAAAATTTAAC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 6643.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM714642. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Hela |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1048188. RNA binding protein: AGO2. Condition:Hela_AGO2_CLIP_ptb_knockdown
... - Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al., 2013, Cell. |
Article |
- Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al. - Cell, 2013
The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.
LinkOut: [PMID: 23313552]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Cardiac Tissues | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM2202477. RNA binding protein: AGO2. Condition:S2_LV_25yo_Male_AGO2_bound_RNA
... - Spengler RM; Zhang X; Cheng C; McLendon JM; et al., 2016, Nucleic acids research. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP.
- Spengler RM; Zhang X; Cheng C; McLendon JM; et al.- Nucleic acids research, 2016
MicroRNAs (miRs) have emerged as key biological effectors in human health and disease. These small noncoding RNAs are incorporated into Argonaute (Ago) proteins, where they direct post-transcriptional gene silencing via base-pairing with target transcripts. Although miRs have become intriguing biological entities and attractive therapeutic targets, the translational impacts of miR research remain limited by a paucity of empirical miR targeting data, particularly in human primary tissues. Here, to improve our understanding of the diverse roles miRs play in cardiovascular function and disease, we applied high-throughput methods to globally profile miR:target interactions in human heart tissues. We deciphered Ago2:RNA interactions using crosslinking immunoprecipitation coupled with high-throughput sequencing (HITS-CLIP) to generate the first transcriptome-wide map of miR targeting events in human myocardium, detecting 4000 cardiac Ago2 binding sites across >2200 target transcripts. Our initial exploration of this interactome revealed an abundance of miR target sites in gene coding regions, including several sites pointing to new miR-29 functions in regulating cardiomyocyte calcium, growth and metabolism. Also, we uncovered several clinically-relevant interactions involving common genetic variants that alter miR targeting events in cardiomyopathy-associated genes. Overall, these data provide a critical resource for bolstering translational miR research in heart, and likely beyond.
LinkOut: [PMID: 27418678]
|
CLIP-seq Support 1 for dataset GSM714642 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000379516.2 | 3UTR | UUAUAUACACACACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1048188 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | Hela / Hela_AGO2_CLIP_ptb_knockdown |
Location of target site | ENST00000379516.2 | 3UTR | GGUUUUAUAUACACACACACAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23313552 / GSE42701 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
95 hsa-miR-497-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT092955 | CYP2U1 | cytochrome P450 family 2 subfamily U member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT124568 | PRRC2B | proline rich coiled-coil 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT125196 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | ![]() |
![]() |
2 | 4 | ||||||
MIRT147296 | KPNA2 | karyopherin subunit alpha 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT163999 | KIAA1109 | KIAA1109 | ![]() |
![]() |
2 | 4 | ||||||
MIRT252495 | NWD1 | NACHT and WD repeat domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT357969 | GRPEL2 | GrpE like 2, mitochondrial | ![]() |
![]() |
2 | 2 | ||||||
MIRT443007 | TRIOBP | TRIO and F-actin binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT443524 | NETO1 | neuropilin and tolloid like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443573 | EVX2 | even-skipped homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443656 | BACH1 | BTB domain and CNC homolog 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT460670 | KRT10 | keratin 10 | ![]() |
![]() |
2 | 8 | ||||||
MIRT464761 | UBE2N | ubiquitin conjugating enzyme E2 N | ![]() |
![]() |
2 | 2 | ||||||
MIRT465032 | LINC00598 | long intergenic non-protein coding RNA 598 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465040 | TTC39C | tetratricopeptide repeat domain 39C | ![]() |
![]() |
2 | 2 | ||||||
MIRT468667 | SEC62 | SEC62 homolog, preprotein translocation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT473694 | MAPK8 | mitogen-activated protein kinase 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT477618 | EFNA3 | ephrin A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480506 | C11orf57 | chromosome 11 open reading frame 57 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480592 | BUB3 | BUB3, mitotic checkpoint protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT486915 | ZNF398 | zinc finger protein 398 | ![]() |
![]() |
2 | 6 | ||||||
MIRT487770 | ANKEF1 | ankyrin repeat and EF-hand domain containing 1 | ![]() |
![]() |
2 | 16 | ||||||
MIRT493265 | MDFIC | MyoD family inhibitor domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT495271 | SLC1A2 | solute carrier family 1 member 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT495309 | CHST12 | carbohydrate sulfotransferase 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496681 | DPP6 | dipeptidyl peptidase like 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT496891 | FOXP1 | forkhead box P1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497330 | IRF4 | interferon regulatory factor 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT498272 | KIAA1644 | KIAA1644 | ![]() |
![]() |
2 | 2 | ||||||
MIRT498634 | CHD4 | chromodomain helicase DNA binding protein 4 | ![]() |
![]() |
2 | 10 | ||||||
MIRT500581 | USP53 | ubiquitin specific peptidase 53 | ![]() |
![]() |
2 | 2 | ||||||
MIRT500751 | TMPPE | transmembrane protein with metallophosphoesterase domain | ![]() |
![]() |
2 | 6 | ||||||
MIRT509668 | ZNF354B | zinc finger protein 354B | ![]() |
![]() |
2 | 10 | ||||||
MIRT510919 | PSMA2 | proteasome subunit alpha 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT519118 | CEP76 | centrosomal protein 76 | ![]() |
![]() |
2 | 2 | ||||||
MIRT526193 | ABCG2 | ATP binding cassette subfamily G member 2 (Junior blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT526746 | HLA-DOB | major histocompatibility complex, class II, DO beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT527270 | FBLN2 | fibulin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528198 | PLEKHM2 | pleckstrin homology and RUN domain containing M2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528330 | TBC1D22B | TBC1 domain family member 22B | ![]() |
![]() |
2 | 2 | ||||||
MIRT530346 | GABRB3 | gamma-aminobutyric acid type A receptor beta3 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT533627 | TMX3 | thioredoxin related transmembrane protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533738 | TMEM200C | transmembrane protein 200C | ![]() |
![]() |
2 | 2 | ||||||
MIRT533779 | TMEM133 | transmembrane protein 133 | ![]() |
![]() |
2 | 2 | ||||||
MIRT534317 | SKIDA1 | SKI/DACH domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538438 | COG5 | component of oligomeric golgi complex 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539156 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539474 | ADARB2 | adenosine deaminase, RNA specific B2 (inactive) | ![]() |
![]() |
2 | 2 | ||||||
MIRT539620 | SHISA9 | shisa family member 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539650 | BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT540346 | OPHN1 | oligophrenin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540412 | PITPNC1 | phosphatidylinositol transfer protein, cytoplasmic 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT541200 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT541395 | CDC27 | cell division cycle 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT546443 | SNX5 | sorting nexin 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547369 | MSI2 | musashi RNA binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT553288 | TSPAN3 | tetraspanin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554402 | SERP1 | stress associated endoplasmic reticulum protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557822 | FOXN2 | forkhead box N2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568530 | ANP32E | acidic nuclear phosphoprotein 32 family member E | ![]() |
![]() |
2 | 2 | ||||||
MIRT569508 | THYN1 | thymocyte nuclear protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570707 | FAM69A | family with sequence similarity 69 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT608376 | PIWIL2 | piwi like RNA-mediated gene silencing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608483 | NKTR | natural killer cell triggering receptor | ![]() |
![]() |
2 | 6 | ||||||
MIRT613533 | TRA2B | transformer 2 beta homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT616601 | ELP2 | elongator acetyltransferase complex subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618166 | DUSP18 | dual specificity phosphatase 18 | ![]() |
![]() |
2 | 2 | ||||||
MIRT632059 | CEP135 | centrosomal protein 135 | ![]() |
![]() |
2 | 2 | ||||||
MIRT647379 | ZDHHC23 | zinc finger DHHC-type containing 23 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648366 | POTED | POTE ankyrin domain family member D | ![]() |
![]() |
2 | 2 | ||||||
MIRT651075 | ZNF518B | zinc finger protein 518B | ![]() |
![]() |
2 | 4 | ||||||
MIRT653618 | SLC30A4 | solute carrier family 30 member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653636 | SLC30A1 | solute carrier family 30 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT654895 | POU2F1 | POU class 2 homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT656232 | MFSD6 | major facilitator superfamily domain containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659880 | CAPRIN1 | cell cycle associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660526 | ARL4C | ADP ribosylation factor like GTPase 4C | ![]() |
![]() |
2 | 2 | ||||||
MIRT666286 | SLC30A3 | solute carrier family 30 member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686808 | SNX2 | sorting nexin 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT695302 | TK1 | thymidine kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT699737 | SERINC3 | serine incorporator 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT700794 | PIAS2 | protein inhibitor of activated STAT 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712270 | PPP1CB | protein phosphatase 1 catalytic subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT712617 | KNSTRN | kinetochore localized astrin/SPAG5 binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT714264 | RPL10A | ribosomal protein L10a | ![]() |
![]() |
2 | 2 | ||||||
MIRT715072 | TMTC1 | transmembrane and tetratricopeptide repeat containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715386 | TADA3 | transcriptional adaptor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716397 | NPAS1 | neuronal PAS domain protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725328 | NFASC | neurofascin | ![]() |
![]() |
2 | 2 | ||||||
MIRT725503 | GANAB | glucosidase II alpha subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT732913 | IRAK2 | interleukin 1 receptor associated kinase 2 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT734890 | SMAD3 | SMAD family member 3 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT737328 | LINC02476 | long intergenic non-protein coding RNA 2476 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT737544 | MALAT1 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | ![]() |
![]() |
![]() |
![]() |
4 | 0 | ||||
MIRT755545 | PAK1 | p21 (RAC1) activated kinase 1 | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|